Published October 2000 | Version v1
Report Restricted

BPA and BSH accumulation in experimental tumors

  • 1. Beth Israel Deaconess Medical Center, Boston, MA (United States)
  • 2. Southampton General Hospital, Wessex Neuro-Center, Southampton (United Kingdom)

Description

The accumulation of boronated compounds into tumors is a critical component to the success of BNCT. To date, great variability has been demonstrated in the tumor:blood ratio achieved in samples both from different patients and within samples taken from the same patient. The factors that probably influence the level of uptake include the vascular perfusion within the tumor, the permeability of these vessels and the viability of the tumor cells themselves. These experiments were designed to measure these various factors in different experimental tumor models and to relate these measurements to the uptake of both BPA (Boronophenylalanine) and BSH (Sodiumborocaptate). They demonstrate that within different tumors there can be wide variations in the vascular parameters. In addition, the viability of the tumor cells may also be an important determinant of tumor uptake. (author)

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Part of:
Proceedings of the ninth international symposium on neutron capture therapy for cancer

Additional details

Publishing Information

Imprint Title
Proceedings of the ninth international symposium on neutron capture therapy for cancer
Imprint Pagination
369 p.
Journal Page Range
p. 59-60
Report number
KURRI-KR--54

Conference

Title
9. international symposium on neutron capture therapy for cancer
Dates
2-6 Oct 2000
Place
Osaka (Japan)

Optional Information

Notes
3 refs., 4 figs.